摘要 |
Disclosed is a pharmaceutical composition for the systematic administration for the treatment of respiratory tract mucositis. The composition comprises therapeutically effective amounts of at least one anti-fungal agent and two or more anti-bacterial agents. The anti-fungal agents are described to include flucytosine, ketoconazole, miconazole, olamine and proprionic acid. The anti-bacterial agents belong to one or more of the classes of tetracyclines, penicillins, macrolides, quinolones, chloramphenicol, rifamycins, sulphonamides, co-trimoxazole, and oxazolidinones.
|